Literature DB >> 24115712

Invasive fungal infections.

William Hope1, Pavithra Natarajan, Lynsey Goodwin.   

Abstract

Entities:  

Keywords:  Aspergillus; Candida; Fungus; antifungal; invasive

Mesh：

Substances：

Year:  2013        PMID： 24115712      PMCID： PMC4953806          DOI： 10.7861/clinmedicine.13-5-507

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  19 in total

1.  Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

Authors:  Johan Maertens; Issam Raad; George Petrikkos; Marc Boogaerts; Dominik Selleslag; Finn B Petersen; Carole A Sable; Nicholas A Kartsonis; Angela Ngai; Arlene Taylor; Thomas F Patterson; David W Denning; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2004-11-09       Impact factor: 9.079

Review 2.  Laboratory diagnosis of invasive aspergillosis.

Authors:  W W Hope; T J Walsh; D W Denning
Journal:  Lancet Infect Dis       Date:  2005-10       Impact factor: 25.071

3.  Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).

Authors:  Oliver A Cornely; Johan Maertens; Mark Bresnik; Ramin Ebrahimi; Andrew J Ullmann; Emilio Bouza; Claus Peter Heussel; Olivier Lortholary; Christina Rieger; Angelika Boehme; Mickael Aoun; Heinz-August Horst; Anne Thiebaut; Markus Ruhnke; Dietmar Reichert; Nicola Vianelli; Stefan W Krause; Eduardo Olavarria; Raoul Herbrecht
Journal:  Clin Infect Dis       Date:  2007-04-09       Impact factor: 9.079

Review 4.  Therapy for fungal diseases: opportunities and priorities.

Authors:  David W Denning; William W Hope
Journal:  Trends Microbiol       Date:  2010-03-06       Impact factor: 17.079

5.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.

Authors:  Ernst-Rüdiger Kuse; Ploenchan Chetchotisakd; Clovis Arns da Cunha; Markus Ruhnke; Carlos Barrios; Digumarti Raghunadharao; Jagdev Singh Sekhon; Antonio Freire; Venkatasubramanian Ramasubramanian; Ignace Demeyer; Marcio Nucci; Amorn Leelarasamee; Frédérique Jacobs; Johan Decruyenaere; Didier Pittet; Andrew J Ullmann; Luis Ostrosky-Zeichner; Olivier Lortholary; Sonja Koblinger; Heike Diekmann-Berndt; Oliver A Cornely
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

7.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

8.  Anidulafungin versus fluconazole for invasive candidiasis.

Authors:  Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; Thomas J Walsh
Journal:  N Engl J Med       Date:  2007-06-14       Impact factor: 91.245

9.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

Authors:  A J Ullmann; M Akova; R Herbrecht; C Viscoli; M C Arendrup; S Arikan-Akdagli; M Bassetti; J Bille; T Calandra; E Castagnola; O A Cornely; J P Donnelly; J Garbino; A H Groll; W W Hope; H E Jensen; B J Kullberg; C Lass-Flörl; O Lortholary; W Meersseman; G Petrikkos; M D Richardson; E Roilides; P E Verweij; M Cuenca-Estrella
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

10.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

Authors:  M Cuenca-Estrella; P E Verweij; M C Arendrup; S Arikan-Akdagli; J Bille; J P Donnelly; H E Jensen; C Lass-Flörl; M D Richardson; M Akova; M Bassetti; T Calandra; E Castagnola; O A Cornely; J Garbino; A H Groll; R Herbrecht; W W Hope; B J Kullberg; O Lortholary; W Meersseman; G Petrikkos; E Roilides; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067
View more
  2 in total

1.  High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines.

Authors:  Ireos Filipuzzi; Simona Cotesta; Francesca Perruccio; Britta Knapp; Yue Fu; Christian Studer; Verena Pries; Ralph Riedl; Stephen B Helliwell; Katarina T Petrovic; N Rao Movva; Dominique Sanglard; Jianshi Tao; Dominic Hoepfner
Journal:  PLoS Genet       Date:  2016-11-17       Impact factor: 5.917

2.  Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection.

Authors:  Piriya Kaeopookum; Dominik Summer; Joachim Pfister; Thomas Orasch; Beatrix E Lechner; Milos Petrik; Zbynek Novy; Barbara Matuszczak; Christine Rangger; Hubertus Haas; Clemens Decristoforo
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.